TOVX icon

Theriva Biologics
TOVX

Overview Fund Trends Analyst Outlook Journalist POV

51 hedge funds and large institutions have $27.9M invested in Theriva Biologics in 2017 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding in top 10

Funds holding in top 10: →

less ownership

Funds ownership: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

4% less funds holding

Funds holding: 53 → 51 (-2)

11% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 9

Holders
51
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$9.75M
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$171K
2
+$163K
3
+$98.1K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$90K
5
PPA
Parametric Portfolio Associates
Washington
+$86K

Top Sellers

1
-$2.12M
2
-$906K
3
-$639K
4
UOC
UBS O'Connor
Illinois
-$424K
5
ECM
Element Capital Management
New York
-$277K
Name Holding Trade Value Shares
Change 		Change in
Stake
51
$4K
52
$3K
53
$1K
54
$1K
55
$1K
56
$1K
57
$20
58
–
59
–
60
–
61
–
62
–
63
–
64
–
65
–
66
–
1 2
3